University of Paris-Sorbonne-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2023

  1. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908

    Neuro-Oncology, Vol. 25, Núm. 8, pp. 1530-1545